• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • Login
  • 0Shopping Cart

  • COVID-19 Resources
  • Knowledge Center
  • Blog
  • Featured
    • View Webinars On-Demand
    • The In Vitro Diagnostics Market: $83 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • Free Downloads
  • About Us
  • Research Index
  • Contact
  • Search
  • Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology
  • Diagnostics
  • Healthcare
  • Medical Devices
  • Pharmaceuticals

Knowledge Center Sidebar

Most Popular Research

  • The Worldwide Market for In Vitro Diagnostics, 13th Edition
  • Clinical Diagnostics MasterFile
  • Benchmarking for 2021: Understanding the Clinical Diagnostics Customer Experience
  • Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
  • At-Home Testing: COVID-19 Trends and Future Potential
    $2,700 – $5,400
    This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  This report covers trends that have occurred since the pandemic was declared in 2020 […]
    April 15, 2021
  • The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 8th Edition
    $4,500 – $9,000
    By the middle of the decade, point of care testing is expected to reach 45 billion dollars annually.  This should not be surprising.  Globally, millions of dollars are spent annually on POC diagnostic testing, both professional testing and self-testing.  In 2020, sales of POC testing reached $29,316 million. COVID-19 was a significant game changer in […]
    April 13, 2021
  • The Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs)
    $3,600 – $7,200
    Contract manufacturing is an increasing part of the pharmaceutical business.  In cell therapy this need is magnified because of the demand for cell and gene therapy products.  Kalorama Information’s report the Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs) details the following: Biopharmaceutical Contract Manufacturing Market Role Services Offered Usage Drivers Profiles of Companies, […]
    April 12, 2021
  • The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, AutoImmune, Others)
    $4,500 – $9,000
    Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and […]
    March 23, 2021
  • 2021 IVD Market Update and COVID-19 Impact
    $3,000 – $6,000
    What is the Size of the IVD Market in 2021? What Impact has COVID-19 Had on IVD Markets? What Major Trends are Affecting the Market in 2021? Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products […]
    March 12, 2021
  • IVD Procedure Volumes 2020-2025: Immunoassays, POC, Chemistry, Molecular, Microbiology and Other Tests
    $4,000 – $8,000
    In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2020-2025 saves time with calculations and estimates of both the existing number of procedures for scores […]
    February 23, 2021
  • COVID-19 Testing Market Update 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends
    $3,000 – $6,000
    As the unfortunate milestone of one full year of the global COVID-19 pandemic worldwide is reached, the diagnostic industry has been changed, perhaps permanently.  Hundreds of test products are on the market to detect the virus, both for its presence and immune response.  And billions of dollars have been added to the in vitro diagnostic market.  […]
    February 16, 2021
  • The Market and Future Potential for Molecular Point of Care
    $4,000 – $8,000
    This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular […]
    January 22, 2021
  • Genetic Testing Markets for Epilepsy, Autism, Alzheimer's and Other Neurologic Conditions
    $4,000 – $8,000
    Genetic involvement in the pathogenesis of neurological disease is significant. Central nervous system disorders account for approximately 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases.  Neurological diseases, especially brain diseases, are the last frontier in medical discovery. Advances in testing such as next-generation sequencing have been instrumental in identifying genetic causes […]
    January 4, 2021
  • Single Cell Genomics Markets
    $5,500 – $11,000
    The study of individual cells has long been an important part of biological research.  Historically this has been a very manual process; some automated technologies are available.  The need for microscopy and other traditional methods has remained, as new methods have also arrived, all of which have been gradually improved.  The ability to amplify DNA […]
    December 23, 2020
Page 1 of 78123›»

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Watch the Companies That Make Cell and Gene Therapies For Pharma, Says New Report April 16, 2021
  • Global Biomarker Test Product Sales to Reach $63 Billion in 2027 April 14, 2021
  • Global IVD Procedures to Grow to 111.3 Billion Annually…Here’s Why April 7, 2021
  • FDA Approves Novel Cell Therapy for Multiple Myeloma March 30, 2021
  • COVID-19 Diagnostics Market Blog: Qiagen secures EUA for COVID-19 test – Labs Still Struggle with Supplies, Says CAP; Cue Health Gets At-Home Approval; FDA Tightens on Variants March 29, 2021

Sitemap

  • Home
  • About
  • Blog
  • Contact

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Scroll to top
Register for Access Login for Access

Register for Access Login for Access

Lost your password? Register